Rotavirus Vaccine Sparks Controversy in Poor Nations
NPR's Joanne Silberner reports on the continuing controversy over a vaccine to prevent one of the leading killers of children in the so-called developing world, the rotavirus. The vaccine is currently too expensive for poor nations to afford, and the pharmaceutical companies developing the vaccine are insisting on more testing.